Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells - PubMed (original) (raw)
Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells
J C Shen et al. Mol Carcinog. 2000 Oct.
Abstract
Genistein, a naturally occurring isoflavone found chiefly in soy products, reportedly has antiprostate cancer effects, but the mechanisms underlying these effects are unknown. We studied the antiproliferative and apoptosis-inducing effects of genistein in the androgen-sensitive human prostate cancer cell line LNCaP. Viable cell number was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay; cell-cycle progression and apoptosis were evaluated by flow cytometry; apoptosis was also assessed by a histone enzyme-linked immunosorbent assay; and the expression of several cell-cycle- and apoptosis-related genes and their gene products was determined by northern blot analysis, western blot analysis, and/or assays based on polymerase chain reaction. Physiologic concentrations of genistein (< or = 20 microM) decreased LNCaP viable cell number in a dose-dependent manner, induced a G(1) cell-cycle block, decreased prostate-specific antigen mRNA expression, and increased p27(KIP1) and p21(WAF1) (mRNA and protein) but had no effect on apoptosis or the mRNA expression of the apoptosis- and cell-cycle-related markers bcl-2, bax, Rb, and proliferating cell nuclear antigen. Higher concentrations of genistein (> 20 microM) did induce apoptosis. We conclude that genistein (at physiologic concentrations) exerts potent antiproliferative effects on LNCaP cells by inducing a G(1) cell-cycle block. The antiproliferative effects of genistein may be mediated by increased levels of p27(KIP1) and p21(WAF1), which are negative cell-cycle regulators that act as cyclin-dependent kinase inhibitors and that have been recently linked with prostate carcinogenesis. These findings may provide insights into the mechanisms underlying the apparent antiprostate cancer effects of soy consumption observed in epidemiologic studies.
Similar articles
- 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y. Muto A, et al. Blood. 1999 Apr 1;93(7):2225-33. Blood. 1999. PMID: 10090931 - Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Chinni SR, et al. Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365. Oncogene. 2001. PMID: 11420705 - Molecular effects of the isoflavonoid genistein in prostate cancer.
Bektic J, Guggenberger R, Eder IE, Pelzer AE, Berger AP, Bartsch G, Klocker H. Bektic J, et al. Clin Prostate Cancer. 2005 Sep;4(2):124-9. doi: 10.3816/cgc.2005.n.021. Clin Prostate Cancer. 2005. PMID: 16197614 Review. - CDK inhibitors: cell cycle arrest versus apoptosis.
Schwartz GK. Schwartz GK. Cell Cycle. 2002 Mar-Apr;1(2):122-3. doi: 10.4161/cc.1.2.115. Cell Cycle. 2002. PMID: 12429920 Review. No abstract available.
Cited by
- The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
Van der Eecken H, Joniau S, Berghen C, Rans K, De Meerleer G. Van der Eecken H, et al. Nutrients. 2023 Nov 21;15(23):4856. doi: 10.3390/nu15234856. Nutrients. 2023. PMID: 38068715 Free PMC article. Review. - Protective Effect of Daidzein against Diethylnitrosamine/Carbon Tetrachloride-Induced Hepatocellular Carcinoma in Male Rats.
Bashandy SAE, Ebaid H, Al-Tamimi J, Hassan I, Omara EA, Elbaset MA, Alhazza IM, Siddique JA. Bashandy SAE, et al. Biology (Basel). 2023 Aug 29;12(9):1184. doi: 10.3390/biology12091184. Biology (Basel). 2023. PMID: 37759583 Free PMC article. - Rottlerin and genistein inhibit neuroblastoma cell proliferation and invasion through EF2K suppression and related protein pathways.
Erdogan MA, Yılmaz OA. Erdogan MA, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Oct;396(10):2481-2500. doi: 10.1007/s00210-023-02473-x. Epub 2023 Apr 21. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37083712 - The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer.
Pejčić T, Zeković M, Bumbaširević U, Kalaba M, Vovk I, Bensa M, Popović L, Tešić Ž. Pejčić T, et al. Antioxidants (Basel). 2023 Feb 3;12(2):368. doi: 10.3390/antiox12020368. Antioxidants (Basel). 2023. PMID: 36829927 Free PMC article. Review. - Genistein: Therapeutic and Preventive Effects, Mechanisms, and Clinical Application in Digestive Tract Tumor.
Hou S. Hou S. Evid Based Complement Alternat Med. 2022 Jun 29;2022:5957378. doi: 10.1155/2022/5957378. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35815271 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous